Cargando…

α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis

Alpha fetoprotein (AFP) is associated with hepatocellular carcinoma (HCC) by stimulating the proliferation, metastasis and drug resistance. The application of AFP fragments to inhibit the malignant behaviours induced by AFP is a new strategy for the treatment of HCC. In an effort to design, screen a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiujiao, Li, Wei, Zhang, Minni, Zou, Zijuan, Dong, Xu, Chen, Yi, Xu, Junnv, Zhu, Mingyue, Li, Mengsen, Lin, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639031/ https://www.ncbi.nlm.nih.gov/pubmed/36181321 http://dx.doi.org/10.1111/jcmm.17565

Ejemplares similares

Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
por: Zhang, Minni, et al.
Publicado: (2023)

Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro
por: Zhu, Mingyue, et al.
Publicado: (2016)

Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
por: Lin, Bo, et al.
Publicado: (2021)

Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells
por: Zhu, Mingyue, et al.
Publicado: (2015)

AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers
por: Lin, Bo, et al.
Publicado: (2021)

Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells
por: Zhu, Mingyue, et al.
Publicado: (2016)

Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells: Erratum
por: Zhu, Mingyue, et al.
Publicado: (2022)

Expression and bioactivity of human α-fetoprotein in a Bac-to-Bac system
por: Lin, Bo, et al.
Publicado: (2017)

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021)

Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
por: Lu, Yan, et al.
Publicado: (2016)

Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
por: Zhu, Mingyue, et al.
Publicado: (2016)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells
por: Feng, Haipeng, et al.
Publicado: (2020)

Inhibition of synthesis of alpha-fetoprotein by glucocorticoids in cultured hepatoma cells
Publicado: (1982)

Benzyl-isothiocyanate Induces Apoptosis and Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells in vitro
por: Zhu, Mingyue, et al.
Publicado: (2017)

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Lee, Sangheun, et al.
Publicado: (2015)

Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes
por: Li, Mengsen, et al.
Publicado: (2005)

Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells
por: Peng, Hai-Shan, et al.
Publicado: (2014)

HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells
por: Zhu, Mingyue, et al.
Publicado: (2015)

Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells
por: Zhu, Mingyue, et al.
Publicado: (2015)

Selective Inhibition of Hepatoma Cells Using Diphtheria Toxin A under the Control of the Promoter/Enhancer Region of the Human α‐Fetoprotein Gene
por: Kunitomi, Michito, et al.
Publicado: (2000)

Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
por: Muraoka, A., et al.
Publicado: (1989)

Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2018)

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
por: Zou, Zijuan, et al.
Publicado: (2023)

Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography
por: Shiozawa, Kazue, et al.
Publicado: (2016)

Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report
por: Xu, Su-Zhen, et al.
Publicado: (2022)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation
por: Zhou, Jian, et al.
Publicado: (2021)

Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation
por: Zhang, Chao, et al.
Publicado: (2016)

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
por: Haga, Yuki, et al.
Publicado: (2017)

Unexpected Role of α-Fetoprotein in Spermatogenesis
por: Yazama, Futoshi, et al.
Publicado: (2011)

Persistent α-Fetoprotein Elevation in Healthy Adults and Mutational Analysis of α-Fetoprotein Promoter, Enhancer, and Silencer Regions
por: Jeon, Yejoo, et al.
Publicado: (2017)

Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity
por: Wang, Wenting, et al.
Publicado: (2019)

Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
por: Lu, Haofeng, et al.
Publicado: (2022)

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein
por: Cui, R, et al.
Publicado: (2003)

Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models
por: Chen, Ying-Jie, et al.
Publicado: (2022)

Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study
por: Bartos, Adrian, et al.
Publicado: (2022)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
por: Hsu, Po‐Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csc41vclgrl4knrcliisgp3lhj